Activator protein 2 alpha (AP2α) suppresses 42 kDa C/CAAT enhancer binding protein α (p42 cEBPα) in head and neck squamous cell carcinoma

International Journal of Cancer

Volumn 124, Issue 6, 2009, Pages 1285-1292

  Bennett, Kristi L ^a,b,c   Romigh, Todd ^c   Arab, Khelifa ^d   Teresi, Rosemary E ^c   Tada, Yasuhiro ^e   Eng, Charts ^c,f   Plass, Christoph ^a,b,d  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e KYUSHU UNIVERSITY HOSPITAL   (Japan)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 aza 2' deoxycitidine (5 aza dC); alternative translation; AP2 ; C CAAT enhancer binding protein alpha (C EBP ); DNA methylation; Head and neck squamous cell carcinoma (HNSCC); P30 C EBP ; p42 C EBP ;

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; ISOPROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, HUMAN; COMPLEMENTARY DNA; PRIMER DNA; RNA;

ARTICLE; BINDING SITE; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; GENE SILENCING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; CELL CYCLE; CELL DIVISION; GENETIC TRANSFECTION; GENETICS; HEAD AND NECK TUMOR; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN SYNTHESIS; SITE DIRECTED MUTAGENESIS; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEINS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; DNA, COMPLEMENTARY; DOWN-REGULATION; HEAD AND NECK NEOPLASMS; HUMANS; MUTAGENESIS, SITE-DIRECTED; PLASMIDS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTEIN BIOSYNTHESIS; RNA, NEOPLASM; TRANSFECTION;

EID: 60549088321     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24087     Document Type: Article

References (26)

1. Schrem H, Klempnauer J, Borlak J. Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site- binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol Rev 2004;56:291-330.
2. Johnson PF. Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J Cell Sci 2005; 118:2545-55.
3. Hsieh CC, Xiong W, Xie Q, Rabek JP, Scott SG, An MR, Reisner PD, Kuninger DT, Papaconstantinou J. Effects of age on the posttranscrip-tional regulation of CCAAT/enhaneer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated livers. Mol Biol Cell 1998;9:1479-94.
4. Porse BT, Bryder D, Theilgaard-Monch K, Hasemann MS, Anderson K, Damgaard T, Jacobsen SE, Neriov C. Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. J Exp Med 2005;202:85-96.
5. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res 2002;62:528-34.
6. Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Liju-zaad P, Tilanus MG, Koole R, Hordijk GJ, van der Vliet PC, Reinderg Ml, Slootweg PJ, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005;37:182-6.
7. Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schul-ier DE, Weber F, Eng C, Plass C. Tumor suppressor activity of CCAAT/enhancer binding protein {alpha} is epigenetically downregulated in head and neck squamous cell carcinoma. Cancer Res 2007;67:4657-64.
8. Jiang MS, Lane MD, Sequential repression and activation of the CCAAT enhancer-binding protein-alpha (C/EBPalpha) gene during adipogenesis. Proc Natl Acad Sci USA 2000;97:12519-23.
9. Jiang JG, DeFrances MC, Machen J, Johnson C, Zarnegar R. The repressive function of AP2 transcription factor on the hepatocyte growth factor gene promoter. Biochem Biophys Res Coramun 21 300:272:882-6.
10. Maytin EV, Lin JC, Krishnamurtliy R, Batchvarova N, Ron D, Mitchell PJ, Habener JF. Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/EBP and AP-2. Dev Biol 1999;216:164-81.
11. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneupioid human keratinocyte cell line. J Ceil Bio 1988;106:761-71.
12. Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, Miron A, Nevins JR. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins, Mol Cell Biol 2000;20:3626-32,
13. Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. J Natl Cancer Inst 2006:98:396-406.
14. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr. Mayo MW. Akt suppresses apoptosis by stimulating the transactiva-tion potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 2000:20:1626-38.
15. Smith LT, Lin M, Brena RM, Lang JC, Sehuller DE, Otterson GA, Morrison CD, Smiraglia DJ, Plass C. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci USA 2006;103:982-7.
16. Kim JW, Monila H, Pandey A, Lane MD. Upstream stimulatory factors regulate the C/EBPalpha gene during differentiation of 3T3-Ll preadipocytes. Biochem Biophys Res Commun 2007:354:517-21.
17. Fatemi M, Wade PA. MBD family proteins: reading the epigenetic code. J Ceil Sci 2006; 119:3033-7.'
18. Matarazzo MR, De Bonis ML, Strazzullo M, Cerase A, Ferraro M, Vastarelli P, Ballestar E, Esteller M, Kudo S, D'Esposito M. Multiple binding of methyl-CpG and polycomb proteins in long-term gene silencing events. J Cell Physiol 2007;210:711-9.
19. Momparler RL. Cancer epigenetics. Oncogene. 2003;22:6479-83.
20. Liu H, Tan BC, Tseng KH,Chuang CP, Yeh CW, Chen KD, Lee SC, Yung BY. Nucleophosmin acts as a novel AP2alpha-binding transcriptional corepressor during cell differentiation, EMBO Rep 2007;8: 394-400.
21. Kaeferstein A. Krug U, Tiesmeier J, Aivado M, Fauihaber M, Stadler M, Krauter J, Germing U, Hofmann WK, Koeffier HP, Ganser A, Ver-beek W. The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML. Leukemia 2003;17:343-9.
22. Cao Z, Umek RM, McKnight SL. Regulated expression of three C7 EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991:5:1538-52.
23. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDL 1) protein. Genes Dev 1996;10:804-15.
24. Lin FT, MacDougald OA, Diehl AM, Lane MD, A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci USA 1993;90:9606-10.
25. Bismuth K, Marie D, Arnheiter H. MTTF and cell proliferation: the role of alternative splice forms. Pigment Cell Res 2005; 18:349-59.
26. Radomska HS, Basseres DS, Zheng R, Zhang P, Dayaram T, Yama-moto T, Sternberg DW, Lokker N, Giese NA, Bohiander SK, Schnittger S, Delmotte MH, et al. Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations'. J Exp Med 2006;203:371-81.